| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193489 | Annals of Allergy, Asthma & Immunology | 2007 | 8 Pages |
Abstract
Ciclesonide possesses several pharmacologic properties of an ideal ICS and has demonstrated an excellent safety profile, indicating that it may be a beneficial treatment for patients with persistent asthma.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Michael A. MD,